V 520
Alternative Names: Ad5 HIV-1 gag; HIV vaccine - Merck & Co; MRKAd5; MRKAd5 env/gag/rev; MRKAd5 gag/pol/nef; MRKAd5 HIV-1 gag; V520Latest Information Update: 24 Oct 2021
At a glance
- Originator Merck & Co
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 22 Sep 2007 Discontinued - Phase-I for HIV-1 infections in Malawi (Injection)
- 22 Sep 2007 Discontinued - Phase-I for HIV-1 infections in Thailand (Injection)
- 22 Sep 2007 Discontinued - Phase-II for HIV-1 infections in Australia (Injection)